Compare CVRX & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVRX | AMTX |
|---|---|---|
| Founded | 2000 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.3M | 113.3M |
| IPO Year | 2021 | 2023 |
| Metric | CVRX | AMTX |
|---|---|---|
| Price | $5.63 | $1.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $10.50 | ★ $12.00 |
| AVG Volume (30 Days) | 311.6K | ★ 1.4M |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 23.02 | ★ 32.98 |
| EPS | N/A | ★ N/A |
| Revenue | $56,651,000.00 | ★ $77,194,000.00 |
| Revenue This Year | $17.17 | $49.77 |
| Revenue Next Year | $17.69 | $57.87 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 10.45 | ★ 174.60 |
| 52 Week Low | $4.37 | $1.30 |
| 52 Week High | $11.30 | $3.80 |
| Indicator | CVRX | AMTX |
|---|---|---|
| Relative Strength Index (RSI) | 52.44 | 37.18 |
| Support Level | $5.06 | $1.56 |
| Resistance Level | $5.99 | $1.85 |
| Average True Range (ATR) | 0.39 | 0.13 |
| MACD | 0.12 | 0.00 |
| Stochastic Oscillator | 70.87 | 27.18 |
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. The operations include California Ethanol, California Dairy Renewable Natural Gas and India Biodiesel. It operates in the reportable geographic segments of North America and India.